Patients' and relatives' perspectives on the quality of end-of-Life care in advanced cancer: From the final months to bereavement

Versluis, M. A. J., van der Linden, Y. M., van Leeuwen-Snoeks, L., van den Beuken-van Everdingen, M. H. J., Hendriks, M. P., van den Borne, B. E. E. M., Sommeijer, D., van Basten, J.-P. A., van der Padt-Pruijsten, A., de Graeff, A., Hunting, J. C. B., Kuip, E. J. M., van Lindert, A. S. R., Youssef-El Soud, M., Thijs-Visser, M. F., Vreugdenhil, A., van Laarhoven, H. W. M., de Jong, W. K., Mandigers, C. & van Zuylen, L. & 4 others, Kloover, J., Smilde, T. J., van de Poll-Franse, L. V. & Raijmakers, N. J. H., 9 Feb 2026, In: PLoS ONE. 21, 2, e0342068.

Research output: Contribution to journal › Article › Academic › peer-review

Actionable Genomic Alterations in Large Cell Neuroendocrine Carcinoma: A European Case Series of Patients Treated With a Small Molecule Inhibitor

Heijboer, F. W. J., Brambilla, M., Occhipinti, M., Lorenzini, D., Buikhuisen, W. A., Kodach, L. L., Christopoulos, P., Stenzinger, A., Hillen, L. M., Garrido, P., Lage, Y., Benito, A., Lindsay, C. R., Carter, M., Herder, J., Britstra, R., van der Drift, M. A., de Jong, W. K., Schutgens, F. W. G. & Damhuis, R. A. M. & 4 others, Speel, E.-J. M., von der Thüsen, J. H., Dingemans, A.-M. C. & Derks, J. L., Nov 2025, In: JCO Precision Oncology. 9, 10 p., e2500293.

Research output: Contribution to journal › Article › Academic › peer-review

DuTOC: The prospective Dutch Thoracic Oncology Cohort: A nationwide infrastructure to collect clinical data, PROMS and bio-material to support thoracic oncology studies

de Jong, W. K., van der Velde, F. T. A., Keijser, A., Groen, H. J. M., van Lindert, A. S. R., Vink, G. R., Hendriks, L. E. L., van den Heuvel, M. M. & DuTOC scientific committee, Oct 2025, In: Lung Cancer. 208, 4 p., 108728.

Research output: Contribution to journal › Article › Academic › peer-review

ETOP 25-23 ADOPT-lung: An international, multicentre, open-label randomised phase III trial to evaluate the benefit of adding adjuvant durvalumab after neoadjuvant chemotherapy plus durvalumab in patients with stage IIB-IIIB (N2) resectable NSCLC

Schmid, S., Dimopoulou, G., van Schil, P., König, D., Mauti, L., Itchins, M., Früh, M., Oselin, K., Landi, L., Pérol, M., Popat, S., Aigner, C., Forde, P., de Jong, W. K., Roschitzki-Voser, H., Grolimund, E., Ruepp, B., Solomon, B., Finn, S. & Dafni, U. & 3 others, Stahel, R., Peters, S. & ETOP 25-23 ADOPT-lung collaborators, Aug 2025, In: Lung Cancer. 206, 108635.

Research output: Contribution to journal › Article › Academic › peer-review

Socioeconomic disparities in health-related quality of life and healthcare use in the last year of life of patients with advanced cancer: longitudinal results from the eQuiPe study

Versluis, M. A. J., van der Linden, Y. M., Oerlemans, S., Sommeijer, D. W., de Jong, W. K., Baars, A., Smilde, T. J., van der Padt-Pruijsten, A., van de Poll-Franse, L. V. & Raijmakers, N. J. H., Apr 2025, In: Supportive Care in Cancer. 33, 4, 11 p., 265.

Research output: Contribution to journal › Article › Academic › peer-review